Pathologic observations in human allograft recipients treated with FK 506.
作者信息
Demetris A J, Fung J J, Todo S, Banner B, Zerbe T, Sysyn G, Starzl T E
机构信息
Departments of Surgery, University of Pittsburgh, PA.
出版信息
Transplant Proc. 1990 Feb;22(1):25-34.
Abstract
摘要
相似文献
1
Pathologic observations in human allograft recipients treated with FK 506.
Transplant Proc. 1990 Feb;22(1):25-34.
2
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
Transplant Proc. 1990 Feb;22(1):6-12.
3
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine.
Transplant Proc. 1991 Feb;23(1 Pt 2):944-6.
4
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
5
Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
J Heart Lung Transplant. 1997 Jul;16(7):723-34.
6
Chronic allograft rejection.
Immunol Rev. 1993 Aug;134:33-81. doi: 10.1111/j.1600-065x.1993.tb00639.x.
7
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
Transplant Proc. 1990 Feb;22(1):37-40.
8
Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
J Heart Lung Transplant. 1997 Sep;16(9):982-4.
9
Liver, kidney, and thoracic organ transplantation under FK 506.
Ann Surg. 1990 Sep;212(3):295-305; discussion 306-7. doi: 10.1097/00000658-199009000-00008.
10
The effects of FK 506 on renal function after liver transplantation.
Transplant Proc. 1990 Feb;22(1):17-20.
引用本文的文献
1
Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity.
BMC Complement Med Ther. 2022 Dec 13;22(1):331. doi: 10.1186/s12906-022-03803-x.
2
Clinicopathologic Characteristics of Centrilobular Injury in Pediatric Liver Transplantation.
Liver Transpl. 2021 Feb;27(3):416-424. doi: 10.1002/lt.25958. Epub 2020 Dec 31.
3
FKBP Ligands-Where We Are and Where to Go?
Front Pharmacol. 2018 Dec 5;9:1425. doi: 10.3389/fphar.2018.01425. eCollection 2018.
4
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
Transplantation. 2000 Jun 15;69(11):2330-6. doi: 10.1097/00007890-200006150-00019.
5
6
Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
J Heart Lung Transplant. 1997 Jul;16(7):723-34.
7
Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.
World J Urol. 1996;14(4):206-17. doi: 10.1007/BF00182069.
8
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.
Am J Surg Pathol. 1996 Mar;20(3):306-12. doi: 10.1097/00000478-199603000-00007.
9
FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.
Clin Chem. 1993 Nov;39(11 Pt 1):2219-28.
10
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.
Am J Surg Pathol. 1993 Jan;17(1):60-8. doi: 10.1097/00000478-199301000-00007.
本文引用的文献
1
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection.
Hepatology. 1984 Nov-Dec;4(6):1212-22. doi: 10.1002/hep.1840040620.
2
Biopsy-directed immunosuppression following hepatic transplantation in man.
Transplantation. 1985 Jun;39(6):589-96. doi: 10.1097/00007890-198506000-00003.
3
Blood and graft eosinophilia as predictors of rejection in human liver transplantation.
Transplantation. 1989 Jan;47(1):72-4. doi: 10.1097/00007890-198901000-00016.
4
Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
Am J Pathol. 1989 Aug;135(2):339-49.
5
Renal transplantation in baboons under FK 506.
Surgery. 1989 Aug;106(2):444-50; discussion 450-1.
6
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs.
Transplantation. 1989 Aug;48(2):193-7. doi: 10.1097/00007890-198908000-00003.
7
8
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506.
Transplantation. 1988 Jan;45(1):206-9. doi: 10.1097/00007890-198801000-00042.
9
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.
Transplantation. 1987 Dec;44(6):734-8. doi: 10.1097/00007890-198712000-00002.
10
Studies of the effects of FK506 on renal allografting in the beagle dog.
Transplantation. 1987 Dec;44(6):729-33. doi: 10.1097/00007890-198712000-00001.
Zotero 插件